Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis

Sanjib Bhattacharyya, Resham Bhattacharya, Steven Curley, Mark A Mc Niven, Priyabrata Mukherjee

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

Treatment with monoclonal antibody (mAbs) is a viable therapeutic option in cancer. Recently, these mAbs such as cetuximab, herceptin, etc., have been used as targeting agents to selectively deliver chemotherapeutics to cancerous cells. However, mechanisms of nanoparticles-mAbs interactions with the target cells and its effect on intracellular trafficking and mechanism are currently unknown. In this paper, we demonstrate that the distinct patterning and dynamics of anti-EGFR (epidermal growth factor receptor) antibody cetuximab (C225)- induced EGFR internalization in pancreatic cancer cells with variable receptor expression is altered upon nano-conjugation. Nanoconjugation uniformly enhanced C225-induced EGFR endocytosis in PANC-1, AsPC-1, and MiaPaca-2 cells, influenced its compartmentalization and regulated the involvement of dynamin-2 in the endocytic processes. Receptor endocytosis and its intracellular trafficking were monitored by confocal microscopy and transmission electron microscopy. The role of dynamin-2 in EGFR endocytosis was determined after overexpressing either wild-type dynamin-2 or mutant dynamin-2 in pancreatic cancer cells followed by tracking the receptor-antibody complex internalization by confocal microscopy. Significantly, these findings demonstrate that the nanoconjugation cannot be construed as an innocuous reaction involved in attaching the targeting agent to the nanoparticle, instead it may distinctly alter the cellular processes at the molecular level, at least antibody induced receptor endocytosis. This information is critical for successful design of a nanoparticle-based targeted drug delivery system for future clinical translation.

Original languageEnglish (US)
Pages (from-to)14541-14546
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume107
Issue number33
DOIs
StatePublished - Aug 17 2010

Fingerprint

Dynamin II
Endocytosis
Nanoparticles
Antibodies
Monoclonal Antibodies
Pancreatic Neoplasms
Confocal Microscopy
Cell Tracking
Drug Delivery Systems
Transmission Electron Microscopy
Epidermal Growth Factor Receptor
Cetuximab
Therapeutics
Neoplasms

Keywords

  • Dynamin
  • EGFR
  • Nanoparticle
  • Pancreatic cancer

ASJC Scopus subject areas

  • General

Cite this

Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis. / Bhattacharyya, Sanjib; Bhattacharya, Resham; Curley, Steven; Mc Niven, Mark A; Mukherjee, Priyabrata.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, No. 33, 17.08.2010, p. 14541-14546.

Research output: Contribution to journalArticle

Bhattacharyya, Sanjib ; Bhattacharya, Resham ; Curley, Steven ; Mc Niven, Mark A ; Mukherjee, Priyabrata. / Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis. In: Proceedings of the National Academy of Sciences of the United States of America. 2010 ; Vol. 107, No. 33. pp. 14541-14546.
@article{6025a11969e2499c939667d83b3d7b71,
title = "Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis",
abstract = "Treatment with monoclonal antibody (mAbs) is a viable therapeutic option in cancer. Recently, these mAbs such as cetuximab, herceptin, etc., have been used as targeting agents to selectively deliver chemotherapeutics to cancerous cells. However, mechanisms of nanoparticles-mAbs interactions with the target cells and its effect on intracellular trafficking and mechanism are currently unknown. In this paper, we demonstrate that the distinct patterning and dynamics of anti-EGFR (epidermal growth factor receptor) antibody cetuximab (C225)- induced EGFR internalization in pancreatic cancer cells with variable receptor expression is altered upon nano-conjugation. Nanoconjugation uniformly enhanced C225-induced EGFR endocytosis in PANC-1, AsPC-1, and MiaPaca-2 cells, influenced its compartmentalization and regulated the involvement of dynamin-2 in the endocytic processes. Receptor endocytosis and its intracellular trafficking were monitored by confocal microscopy and transmission electron microscopy. The role of dynamin-2 in EGFR endocytosis was determined after overexpressing either wild-type dynamin-2 or mutant dynamin-2 in pancreatic cancer cells followed by tracking the receptor-antibody complex internalization by confocal microscopy. Significantly, these findings demonstrate that the nanoconjugation cannot be construed as an innocuous reaction involved in attaching the targeting agent to the nanoparticle, instead it may distinctly alter the cellular processes at the molecular level, at least antibody induced receptor endocytosis. This information is critical for successful design of a nanoparticle-based targeted drug delivery system for future clinical translation.",
keywords = "Dynamin, EGFR, Nanoparticle, Pancreatic cancer",
author = "Sanjib Bhattacharyya and Resham Bhattacharya and Steven Curley and {Mc Niven}, {Mark A} and Priyabrata Mukherjee",
year = "2010",
month = "8",
day = "17",
doi = "10.1073/pnas.1006507107",
language = "English (US)",
volume = "107",
pages = "14541--14546",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "33",

}

TY - JOUR

T1 - Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis

AU - Bhattacharyya, Sanjib

AU - Bhattacharya, Resham

AU - Curley, Steven

AU - Mc Niven, Mark A

AU - Mukherjee, Priyabrata

PY - 2010/8/17

Y1 - 2010/8/17

N2 - Treatment with monoclonal antibody (mAbs) is a viable therapeutic option in cancer. Recently, these mAbs such as cetuximab, herceptin, etc., have been used as targeting agents to selectively deliver chemotherapeutics to cancerous cells. However, mechanisms of nanoparticles-mAbs interactions with the target cells and its effect on intracellular trafficking and mechanism are currently unknown. In this paper, we demonstrate that the distinct patterning and dynamics of anti-EGFR (epidermal growth factor receptor) antibody cetuximab (C225)- induced EGFR internalization in pancreatic cancer cells with variable receptor expression is altered upon nano-conjugation. Nanoconjugation uniformly enhanced C225-induced EGFR endocytosis in PANC-1, AsPC-1, and MiaPaca-2 cells, influenced its compartmentalization and regulated the involvement of dynamin-2 in the endocytic processes. Receptor endocytosis and its intracellular trafficking were monitored by confocal microscopy and transmission electron microscopy. The role of dynamin-2 in EGFR endocytosis was determined after overexpressing either wild-type dynamin-2 or mutant dynamin-2 in pancreatic cancer cells followed by tracking the receptor-antibody complex internalization by confocal microscopy. Significantly, these findings demonstrate that the nanoconjugation cannot be construed as an innocuous reaction involved in attaching the targeting agent to the nanoparticle, instead it may distinctly alter the cellular processes at the molecular level, at least antibody induced receptor endocytosis. This information is critical for successful design of a nanoparticle-based targeted drug delivery system for future clinical translation.

AB - Treatment with monoclonal antibody (mAbs) is a viable therapeutic option in cancer. Recently, these mAbs such as cetuximab, herceptin, etc., have been used as targeting agents to selectively deliver chemotherapeutics to cancerous cells. However, mechanisms of nanoparticles-mAbs interactions with the target cells and its effect on intracellular trafficking and mechanism are currently unknown. In this paper, we demonstrate that the distinct patterning and dynamics of anti-EGFR (epidermal growth factor receptor) antibody cetuximab (C225)- induced EGFR internalization in pancreatic cancer cells with variable receptor expression is altered upon nano-conjugation. Nanoconjugation uniformly enhanced C225-induced EGFR endocytosis in PANC-1, AsPC-1, and MiaPaca-2 cells, influenced its compartmentalization and regulated the involvement of dynamin-2 in the endocytic processes. Receptor endocytosis and its intracellular trafficking were monitored by confocal microscopy and transmission electron microscopy. The role of dynamin-2 in EGFR endocytosis was determined after overexpressing either wild-type dynamin-2 or mutant dynamin-2 in pancreatic cancer cells followed by tracking the receptor-antibody complex internalization by confocal microscopy. Significantly, these findings demonstrate that the nanoconjugation cannot be construed as an innocuous reaction involved in attaching the targeting agent to the nanoparticle, instead it may distinctly alter the cellular processes at the molecular level, at least antibody induced receptor endocytosis. This information is critical for successful design of a nanoparticle-based targeted drug delivery system for future clinical translation.

KW - Dynamin

KW - EGFR

KW - Nanoparticle

KW - Pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=77957057901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957057901&partnerID=8YFLogxK

U2 - 10.1073/pnas.1006507107

DO - 10.1073/pnas.1006507107

M3 - Article

C2 - 20679244

AN - SCOPUS:77957057901

VL - 107

SP - 14541

EP - 14546

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 33

ER -